Larry Mathis Financial Planning’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.38M Sell
5,279
-416
-7% -$107K 1.18% 11
2026
Q2
$1.43M Buy
+5,695
New +$1.23M 1.09% 16

Other funds holding ABBV

Larry Mathis Financial Planning's ABBV Position: Q3 2026 in Review

Larry Mathis Financial Planning reduced its AbbVie (ABBV) stake by 7.3% in Q3 2026, selling an estimated $107K and leaving 5,279 shares worth $1.38M. The position accounts for 1.18% of the portfolio, ranked #11.

Larry Mathis Financial Planning first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.43M in Q2 2026. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Larry Mathis Financial Planning held 5,279 shares of AbbVie worth $1.38M as of Q3 2026.
  • Larry Mathis Financial Planning sold 416 AbbVie shares in Q3 2026, an estimated $107K.
  • AbbVie made up 1.18% of Larry Mathis Financial Planning's portfolio in Q3 2026, its #11 holding.
  • Larry Mathis Financial Planning first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • Larry Mathis Financial Planning's AbbVie position peaked at $1.43M in Q2 2026.
  • 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Larry Mathis Financial Planning's 13F filing for Q3 2026, filed 26 Oct 2026.